Back to results
US 2025/0090465 A1Published application
Formulations of Enzalutamide
AssigneesAstellas Pharma Inc., Medivation Prostate Therapeutics, Inc.
InventorsDouglas Alan Lorenz, Sanjay Konagurthu, Randy J. Wald, Jason A. Everett, Sheila Matz, Yuuki Takaishi, Toshiro Sakai, Ryousuke Irie, Shinsuke Oba, Hiroyasu Toyota, Koji Nishimura, Atsushi Kanbayashi
Life of this patent
Estimating the term…
Abstract
This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
Claims1
A method of treating prostate cancer comprising administering to a patient in need thereof a tablet comprising a solid dispersion comprising amorphous enzalutamide and hydroxypropyl methylcellulose acetate succinate.
Dependencies are inferred from the claim text.